A32 Session 9: Women’s Health
Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be m...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Sabel, Michael [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Übergeordnetes Werk: |
Enthalten in: Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications - Strong, J.W.D. ELSEVIER, 2022, international journal of low temperature biology and medicine, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:69 ; year:2014 ; number:1 ; pages:192 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.cryobiol.2014.06.041 |
|---|
| Katalog-ID: |
ELV02842560X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV02842560X | ||
| 003 | DE-627 | ||
| 005 | 20230625155738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cryobiol.2014.06.041 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014020000016.pica |
| 035 | |a (DE-627)ELV02842560X | ||
| 035 | |a (ELSEVIER)S0011-2240(14)00168-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 | |
| 082 | 0 | 4 | |a 570 |q DE-600 |
| 082 | 0 | 4 | |a 550 |q VZ |
| 084 | |a 38.00 |2 bkl | ||
| 100 | 1 | |a Sabel, Michael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A32 Session 9: Women’s Health |
| 264 | 1 | |c 2014transfer abstract | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. | ||
| 520 | |a Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. | ||
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Strong, J.W.D. ELSEVIER |t Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |d 2022 |d international journal of low temperature biology and medicine |g Orlando, Fla |w (DE-627)ELV008369550 |
| 773 | 1 | 8 | |g volume:69 |g year:2014 |g number:1 |g pages:192 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cryobiol.2014.06.041 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 38.00 |j Geowissenschaften: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 69 |j 2014 |e 1 |h 192 | ||
| 953 | |2 045F |a 570 | ||
| author_variant |
m s ms |
|---|---|
| matchkey_str |
sabelmichael:2014----:3ssinwm |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
38.00 |
| publishDate |
2014 |
| allfields |
10.1016/j.cryobiol.2014.06.041 doi GBVA2014020000016.pica (DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 DE-627 ger DE-627 rakwb eng 570 570 DE-600 550 VZ 38.00 bkl Sabel, Michael verfasserin aut A32 Session 9: Women’s Health 2014transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Enthalten in Academic Press Strong, J.W.D. ELSEVIER Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications 2022 international journal of low temperature biology and medicine Orlando, Fla (DE-627)ELV008369550 volume:69 year:2014 number:1 pages:192 https://doi.org/10.1016/j.cryobiol.2014.06.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.00 Geowissenschaften: Allgemeines VZ AR 69 2014 1 192 045F 570 |
| spelling |
10.1016/j.cryobiol.2014.06.041 doi GBVA2014020000016.pica (DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 DE-627 ger DE-627 rakwb eng 570 570 DE-600 550 VZ 38.00 bkl Sabel, Michael verfasserin aut A32 Session 9: Women’s Health 2014transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Enthalten in Academic Press Strong, J.W.D. ELSEVIER Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications 2022 international journal of low temperature biology and medicine Orlando, Fla (DE-627)ELV008369550 volume:69 year:2014 number:1 pages:192 https://doi.org/10.1016/j.cryobiol.2014.06.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.00 Geowissenschaften: Allgemeines VZ AR 69 2014 1 192 045F 570 |
| allfields_unstemmed |
10.1016/j.cryobiol.2014.06.041 doi GBVA2014020000016.pica (DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 DE-627 ger DE-627 rakwb eng 570 570 DE-600 550 VZ 38.00 bkl Sabel, Michael verfasserin aut A32 Session 9: Women’s Health 2014transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Enthalten in Academic Press Strong, J.W.D. ELSEVIER Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications 2022 international journal of low temperature biology and medicine Orlando, Fla (DE-627)ELV008369550 volume:69 year:2014 number:1 pages:192 https://doi.org/10.1016/j.cryobiol.2014.06.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.00 Geowissenschaften: Allgemeines VZ AR 69 2014 1 192 045F 570 |
| allfieldsGer |
10.1016/j.cryobiol.2014.06.041 doi GBVA2014020000016.pica (DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 DE-627 ger DE-627 rakwb eng 570 570 DE-600 550 VZ 38.00 bkl Sabel, Michael verfasserin aut A32 Session 9: Women’s Health 2014transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Enthalten in Academic Press Strong, J.W.D. ELSEVIER Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications 2022 international journal of low temperature biology and medicine Orlando, Fla (DE-627)ELV008369550 volume:69 year:2014 number:1 pages:192 https://doi.org/10.1016/j.cryobiol.2014.06.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.00 Geowissenschaften: Allgemeines VZ AR 69 2014 1 192 045F 570 |
| allfieldsSound |
10.1016/j.cryobiol.2014.06.041 doi GBVA2014020000016.pica (DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 DE-627 ger DE-627 rakwb eng 570 570 DE-600 550 VZ 38.00 bkl Sabel, Michael verfasserin aut A32 Session 9: Women’s Health 2014transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. Enthalten in Academic Press Strong, J.W.D. ELSEVIER Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications 2022 international journal of low temperature biology and medicine Orlando, Fla (DE-627)ELV008369550 volume:69 year:2014 number:1 pages:192 https://doi.org/10.1016/j.cryobiol.2014.06.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO 38.00 Geowissenschaften: Allgemeines VZ AR 69 2014 1 192 045F 570 |
| language |
English |
| source |
Enthalten in Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications Orlando, Fla volume:69 year:2014 number:1 pages:192 |
| sourceStr |
Enthalten in Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications Orlando, Fla volume:69 year:2014 number:1 pages:192 |
| format_phy_str_mv |
Article |
| bklname |
Geowissenschaften: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |
| authorswithroles_txt_mv |
Sabel, Michael @@aut@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008369550 |
| dewey-sort |
3570 |
| id |
ELV02842560X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02842560X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625155738.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cryobiol.2014.06.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014020000016.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02842560X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0011-2240(14)00168-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sabel, Michael</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A32 Session 9: Women’s Health</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Strong, J.W.D. ELSEVIER</subfield><subfield code="t">Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications</subfield><subfield code="d">2022</subfield><subfield code="d">international journal of low temperature biology and medicine</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV008369550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:69</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:192</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cryobiol.2014.06.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.00</subfield><subfield code="j">Geowissenschaften: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">69</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">192</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
| author |
Sabel, Michael |
| spellingShingle |
Sabel, Michael ddc 570 ddc 550 bkl 38.00 A32 Session 9: Women’s Health |
| authorStr |
Sabel, Michael |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008369550 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 550 - Earth sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 570 DE-600 550 VZ 38.00 bkl A32 Session 9: Women’s Health |
| topic |
ddc 570 ddc 550 bkl 38.00 |
| topic_unstemmed |
ddc 570 ddc 550 bkl 38.00 |
| topic_browse |
ddc 570 ddc 550 bkl 38.00 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |
| hierarchy_parent_id |
ELV008369550 |
| dewey-tens |
570 - Life sciences; biology 550 - Earth sciences & geology |
| hierarchy_top_title |
Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008369550 |
| title |
A32 Session 9: Women’s Health |
| ctrlnum |
(DE-627)ELV02842560X (ELSEVIER)S0011-2240(14)00168-0 |
| title_full |
A32 Session 9: Women’s Health |
| author_sort |
Sabel, Michael |
| journal |
Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |
| journalStr |
Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
192 |
| author_browse |
Sabel, Michael |
| container_volume |
69 |
| class |
570 570 DE-600 550 VZ 38.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sabel, Michael |
| doi_str_mv |
10.1016/j.cryobiol.2014.06.041 |
| dewey-full |
570 550 |
| title_sort |
a32 session 9: women’s health |
| title_auth |
A32 Session 9: Women’s Health |
| abstract |
Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. |
| abstractGer |
Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. |
| abstract_unstemmed |
Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO |
| container_issue |
1 |
| title_short |
A32 Session 9: Women’s Health |
| url |
https://doi.org/10.1016/j.cryobiol.2014.06.041 |
| remote_bool |
true |
| ppnlink |
ELV008369550 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.cryobiol.2014.06.041 |
| up_date |
2024-07-06T18:46:51.961Z |
| _version_ |
1803856497303617536 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02842560X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625155738.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cryobiol.2014.06.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014020000016.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02842560X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0011-2240(14)00168-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sabel, Michael</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A32 Session 9: Women’s Health</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Given the ease of delivery and patient comfort associated with cryoablation, and its success in other areas, there has been significant interest in cryoablation for gynecologic care. In some cases, cryoablation has proved a viable alternative, while in other areas, there are still challenges to be met. For two of the most common gynecologic disorders; fibroid tumors and excessive uterine bleeding, the use of cryoablation has been examined. In both cases, cryoablation is one of several established and experimental therapeutic options, with relative advantages and disadvantages compared with alternatives. Cryoablation has also been used in the treatment of gynecologic malignancies. For some cancers, while primary ablation has been studied, the use of cryoablation has been primarily palliative, in cases where surgical removal was not appropriate. In other cases, such as cervical cancer, cryotherapy may play a role in the management of early stage disease (cervical intraepithelial neoplasia). This presentation will examine the role of cryoablation in women’s health, including its limitations and indications compared with alternative therapies.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Strong, J.W.D. ELSEVIER</subfield><subfield code="t">Eo-Paleoarchean detrital zircon in the Winnipeg River terrane, Western Superior Province: Provenance and implications</subfield><subfield code="d">2022</subfield><subfield code="d">international journal of low temperature biology and medicine</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV008369550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:69</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:192</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cryobiol.2014.06.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.00</subfield><subfield code="j">Geowissenschaften: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">69</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">192</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
| score |
7.3999777 |